Hyperfractioned Regional Nodal Irradiation for women with invasive breast cancer
- Trial ID:
- IRB-22-7881
- Ray Lin, M.D.
Inclusion Criteria
Patients must:
- Be 18 years or older
Have pathologically confirmed invasive breast cancer
Prior mastectomy or lumpectomy with axillary evaluation
Exclusion Criteria
Patients must not:
- Have clinical or pathological evidence of metastases
Have cancer diagnosed in both breasts
Have had previous irradiation to breast, neck, or chest
Additional Info
Radiation treatments will be performed at Prebys Cancer Center in Hillcrest and Scripps MD Anderson Cancer Center in La Jolla.Each participant will be followed for 10 years and will be expected to complete a series of questionnaires at certain time points.
For more information, search for NCT02912312 at www.clinicaltrials.gov
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org